Mr. Boris Jordan reports

CURALEAF RECEIVES ALL REQUIRED COMPETITION LAW CLEARANCES FOR PROPOSED ACQUISITION OF AURORA CANNABIS

Curaleaf Holdings Inc. has received competition law clearances in Germany and Canada for its proposed acquisition of Aurora Cannabis Inc. Germany and Canada are the only jurisdictions in which competition law clearance was required for Curaleaf's proposed acquisition.

On Oct. 20, 2026, Germany's Federal Ministry for Economic Affairs and Energy granted approval for the proposed acquisition of 100 per cent of the voting rights in Aurora Europe GmbH, Aurora Deutschland GmbH and Aurora Produktions GmbH by Curaleaf Holdings.

On Nov. 2, 2026, Canada's Competition Bureau issued a no-action letter confirming that the interim Commissioner of Competition had concluded her review and did not, at that time, intend to make an application under Section 92 of the Competition Act (Canada) regarding the proposed acquisition of up to all of the issued and outstanding common shares of Aurora Cannabis.

On Nov. 3, 2026, Germany's Federal Cartel Office confirmed that the proposed acquisition does not meet the conditions for prohibition under German competition law and may be implemented.

Curaleaf's enhanced premium bid of Oct. 6, 2026, to purchase all of the outstanding common shares of Aurora remains outstanding and is set to expire on Dec. 4, 2026, unless withdrawn or amended.

"With all required competition law clearances secured, the path is clear for Aurora shareholders to realize the value our offer provides," said Boris Jordan, chairman of the board and chief executive officer of Curaleaf. "We appreciate the constructive engagement of the regulators who reviewed the transaction."

Curaleaf's required competition law reviews are complete while Organigram's proposed acquisition remains subject to shareholder, court and regulatory approvals. Curaleaf believes these clearances strengthen its offer by providing greater certainty of completion and supporting a faster path to closing, subject to the offer's remaining conditions being satisfied or waived. The company believes Aurora shareholders should consider this advantage when evaluating the competing proposals.

About Curaleaf Holdings Inc.

Curaleaf is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, Curaleaf and its brands, including Curaleaf, Select, Grassroots, Find, Dark Heart and Anthem, provide industry-leading service, product selection and accessibility across the medical and adult use markets. Curaleaf International is powered by a strong presence in all stages of the supply chain. Its unique distribution network throughout Europe, Canada and Australasia brings together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf's subordinate voting shares are listed on the Toronto Stock Exchange under the symbol CURA and trade on the OTCQX market under the symbol CURLF.

We seek Safe Harbor.